Company: SNWV
Filing Date: 2025-07-10
Form Type: DEF 14A
Source: 0001140361-25-025486
Chunk: 22

Company: SANUWAVE Health, Inc.
Filing Date: 2025-07-10
Form: DEF 14A
Chunk 22
---
ILLY AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025. 14 TABLE OF CONTENTS Audit Committee Report The Audit Committee reviews the Company’s financial reporting process on behalf of the Board. Management has the primary responsibility for the preparation and integrity of the consolidated financial statements and the reporting process, including establishing and monitoring the system of internal financial controls. In this context, during the fiscal year ended December 31, 2024, the Audit Committee met and held discussions with management and Marcum LLP (“Marcum”), the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2024. Management has represented to the Audit Committee that the Company’s consolidated financial statements for the fiscal year ended December 31, 2024 were prepared in accordance with generally accepted accounting principles in the United States, and the Audit Committee has reviewed and discussed the Company’s audited financial statements with management and with Marcum. In addition, the Audit Committee has reviewed and discussed with Marcum: (i) the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the “PCAOB”) and the Securities and Exchange Commission (the “SEC”); and (ii) the written disclosures and the letter received from Marcum required by applicable requirements of the PCAOB regarding Marcum’s communications with the Audit Committee concerning independence and the independence of Marcum from the Company and management. Based on the review and discussion referred to above, the Audit Committee recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for filing with the SEC. Audit Committee Ian Miller, Chair Jeffrey Blizard James Tyler 15

TABLE OF CONTENTS

PROPOSAL 3: APPROVAL OF THE AMENDMENT TO THE 2024 EQUITY INCENTIVE PLAN The 2024 Plan originally became effective August 7, 2024. On June 6, 2025, the Board approved an amendment to the 2024 Plan to increase the total number of shares of common stock authorized for issuance under the 2024 Plan by 500,000 shares (the “Amendment”) in accordance with the recommendation of the Compensation Committee and directed that the Amendment be submitted to stockholders for approval at the Stockholder Meeting. If our stockholders do not approve this proposal, the Amendment described in this proposal will